<DOC>
	<DOCNO>NCT02790723</DOCNO>
	<brief_summary>This study seek determine safety three different dos sc-rAAV2.5IL-1Ra delivered intra-articular injection one knee joint patient moderate OA knee .</brief_summary>
	<brief_title>Safety Intra-Articular Sc-rAAV2.5IL-1Ra Subjects With Moderate Knee OA</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Age 1865 year Gender : male female Target disease : Moderate OA knee Persistent symptom , despite standard NSAID Normal limit follow : Complete blood count Prothrombin Time , Activated partial thromboplastin time Blood chemistry ( Glucose , Na , K , Cl , CO2 , BUN , creatinine , Ca , PO4 , magnesium , uric acid ) Liver function test ( amylase , total bilirubin , alkaline phosphate , GGT , AST , ALT , total protein , albumin ) Able willing return Mayo Clinic followup visit , require study Able undergo MRI knee Subjects able give appropriate consent appropriate representative available . Potential subject fail threemonth trial minimum two conservative therapy consider trial . These conservative therapy include : activity modification , weight loss , physical therapy , antiinflammatory injection therapy . Pregnant , currently breastfeed Ongoing infectious disease include HIV , HTLV , hepatitis , syphilis tuberculosis positive Individuals OA part another syndrome ( e.g . Ehler 's Danlos , Stickler syndrome , etc . ) Systemic , rheumatic inflammatory disease knee chondrocalcinosis , hemochromatosis , inflammatory arthritis , arthropathy knee associate juxtaarticular Paget 's disease femur tibia , ochronosis , hemophilic arthropathy , infectious arthritis , Charcot 's knee joint , villonodular synovitis , synovial chondromatosis . Clinically significant cardiovascular , renal , hepatic , endocrine disease , diabetes , cancer , autoimmune disease ; serious infection major operation within 30 day enrollment ; history psychiatric disease recent history alcoholism drug addiction . Currently take immunosuppressant medication Anticipated major surgery study period . Individuals involve another protocol , treat one within last 3 month . Intraarticular therapy index knee within previous 6 month . Surgery target knee within 6 month prior screen . Surgery weight bear joint interfere knee assessment Prior articular transplant procedure Prior reconstruction surgery target knee within 12 month Xray finding acute fracture Known severe loss bone density , and/or severe bone joint deformity target knee . Knee pain associated patellafemoral arthritis chondromalacia target knee . Significant target knee infection overlie skin disorder/infection within previous 6 month prior study enrollment Require cane assistive device walk Symptomatic OA hip , spine ankle would interfere evaluation target knee , History document nerve damage affect limb , vascular insufficiency , Condition require use systemic steroid , Coagulation disorder . Patients unstable knee Temperature 99.5 F. Elevated liver transaminase Identification member vulnerable population . BMI great 40 . History allergy local anesthetic Currently take antirheumatic disease medication ( include methotrexate antimetabolite ) within 3 month prior entry study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>